Clinical Trials on Somatostatin Receptor Positive in Japan
Total 129 results
-
Novartis PharmaceuticalsActive, not recruitingSomatostatin Receptor-positive Neuroendocrine TumorJapan
-
Osaka Medical CollegeTerminatedBreast Cancer | HER-2 Positive Breast Cancer | Estrogen Receptor Negative NeoplasmJapan
-
Toshihiko KonoUnknown
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive, HER2-negative, Advanced Breast CancerJapan, Hong Kong, Singapore
-
Toshihiko KonoUnknownSelective Estrogen Receptor Modulator (SERM)Japan
-
Kyoto Breast Cancer Research NetworkPfizerCompletedHormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer FemaleTaiwan, Japan, Korea, Republic of, Australia, Hong Kong
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
AstraZenecaActive, not recruitingHormone Receptor Positive Breast CancerCanada, Spain, United States, Romania, Taiwan, Italy, Brazil, Peru, Russian Federation, China, Czechia, Ukraine, South Africa, Japan, Poland, Mexico, United Kingdom, Argentina, Slovakia, Turkey
-
Eisai Co., Ltd.Completed
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
PfizerRecruitingEGFR Mutation-positive Inoperable or Reccrent NSCLCJapan
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
Sanofi Pasteur, a Sanofi CompanyCompletedClostridium Difficile InfectionJapan
-
Tokyo Study GroupCompletedGAD Ab Positive Clinically Type 2 Diabetic PatientsJapan
-
Merck Sharp & Dohme LLCCompleted
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Pharmaceutical K.K.CompletedTuberculosis, Multidrug-ResistantJapan
-
PfizerCompletedStaphylococcal InfectionsJapan
-
Osaka Medical CollegeCompletedBreast Cancer | Effects of Chemotherapy | HER-2 Positive Breast CancerJapan
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Japan
-
TakedaCompletedUntreated CD30-Positive Hodgkin's LymphomaJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedClostridium Difficile InfectionJapan
-
National Cancer Center, JapanH.U. Group Research Institute G.K.RecruitingHER2-positive Breast CancerJapan
-
PfizerCompletedClostridium Difficile Associated DiseaseJapan
-
Janssen Pharmaceutical K.K.RecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorJapan
-
Kanto CML Study GroupUnknownLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Myelogenous Leukemia, Chronic, Chronic PhaseJapan
-
Kanto CML Study GroupEpidemiological and Clinical Research Information NetworkCompleted
-
Kanto CML Study GroupEpidemiological and Clinical Research Information NetworkCompletedChronic Myeloid LeukemiaJapan
-
Daiichi Sankyo Co., Ltd.AstraZeneca; Daiichi Sankyo, Inc.RecruitingTriple Negative Breast Cancer | Non-small Cell Lung Cancer | Hormone Receptor Positive Breast CancerUnited States, Japan
-
National Hospital Organization Minami Kyoto HospitalCompletedEmaciation | Energy Metabolism | Pulmonary MACJapan
-
PfizerCompletedStreptococcus Pneumoniae | Pneumococcal VaccineJapan
-
Kyoto UniversityCompletedSleep Apnea | Continuous Positive Airway Pressure | Prostaglandins | Circadian VariationsJapan
-
Astellas Pharma IncCompleted
-
Kyoto University, Graduate School of MedicineCompletedInflammation | Obstructive Sleep Apnea | Continuous Positive Airway PressureJapan
-
PfizerCompletedPneumococcal InfectionsJapan
-
Kanto CML Study GroupUnknownMyelogenous Leukemia, Chronic, Chronic PhaseJapan
-
Janssen Research & Development, LLCCompletedUrothelial Cancer | Receptors, Fibroblast Growth FactorUnited States, Italy, Belgium, United Kingdom, Japan, Turkey, Brazil, Ukraine, Spain, Russian Federation, Israel, France, Germany, Argentina
-
Kameda Medical CenterMerck Sharp & Dohme LLC; PPD; Osaka UniversityCompletedInfluenza | Pneumococcal PneumoniaJapan
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Chronic Myelogenous LeukemiaJapan
-
GlaxoSmithKlineCompletedInfections, StreptococcalJapan
-
National Cancer Center Hospital EastBayer Yakuhin, Ltd.Active, not recruitingSalivary Gland CancerJapan
-
PfizerCompletedPneumococcal DiseaseJapan
-
Osaka UniversityCompletedPulmonary TuberculosisJapan
-
Shimousa Hematology Study GroupEpidemiological and Clinical Research Information NetworkUnknown
-
Merck Sharp & Dohme LLCCompletedPneumococcal DiseaseJapan
-
Keio UniversityCompletedAcute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaJapan
-
Japan Breast Cancer Research GroupChugai PharmaceuticalUnknownHER2-positive Locally Advanced or Metastatic Breast CancerJapan
-
National Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerUnited States, Japan